This article needs attention from an expert on the subject. Please add a reason or a talk parameter to this template to explain the issue with the article. When placing this tag, consider associating this request with a WikiProject.(July 2017)
↑Lee JA, Park JE, Lee DH, Park SG, Myung PK, Park BC, Cho S (Feb 2008). "G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1". Oncogene. 27 (9): 1297–305. doi:10.1038/sj.onc.1210740. PMID17700517.
↑Hegde R, Srinivasula SM, Datta P, Madesh M, Wassell R, Zhang Z, Cheong N, Nejmeh J, Fernandes-Alnemri T, Hoshino S, Alnemri ES (Oct 2003). "The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein". The Journal of Biological Chemistry. 278 (40): 38699–706. doi:10.1074/jbc.M303179200. PMID12865429.
Further reading
Ozawa K, Murakami Y, Eki T, Yokoyama K, Soeda E, Hoshino S, Ui M, Hanaoka F (Mar 1992). "Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1". Somatic Cell and Molecular Genetics. 18 (2): 189–94. doi:10.1007/BF01233164. PMID1574740.
Hoshino S, Imai M, Mizutani M, Kikuchi Y, Hanaoka F, Ui M, Katada T (Aug 1998). "Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1". The Journal of Biological Chemistry. 273 (35): 22254–9. doi:10.1074/jbc.273.35.22254. PMID9712840.
Merkulova TI, Frolova LY, Lazar M, Camonis J, Kisselev LL (Jan 1999). "C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction". FEBS Letters. 443 (1): 41–7. doi:10.1016/S0014-5793(98)01669-X. PMID9928949.
Hoshino S, Imai M, Kobayashi T, Uchida N, Katada T (Jun 1999). "The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein". The Journal of Biological Chemistry. 274 (24): 16677–80. doi:10.1074/jbc.274.24.16677. PMID10358005.
Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T, Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL, Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD (Sep 1999). "Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q". Genomics. 60 (3): 295–308. doi:10.1006/geno.1999.5927. PMID10493829.
Cosson B, Berkova N, Couturier A, Chabelskaya S, Philippe M, Zhouravleva G (Sep 2002). "Poly(A)-binding protein and eRF3 are associated in vivo in human and Xenopus cells". Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 94 (4–5): 205–16. doi:10.1016/S0248-4900(02)01194-2. PMID12489690.
Hegde R, Srinivasula SM, Datta P, Madesh M, Wassell R, Zhang Z, Cheong N, Nejmeh J, Fernandes-Alnemri T, Hoshino S, Alnemri ES (Oct 2003). "The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein". The Journal of Biological Chemistry. 278 (40): 38699–706. doi:10.1074/jbc.M303179200. PMID12865429.
Le Roy F, Salehzada T, Bisbal C, Dougherty JP, Peltz SW (Jun 2005). "A newly discovered function for RNase L in regulating translation termination". Nature Structural & Molecular Biology. 12 (6): 505–12. doi:10.1038/nsmb944. PMID15908960.
Brito M, Malta-Vacas J, Carmona B, Aires C, Costa P, Martins AP, Ramos S, Conde AR, Monteiro C (Dec 2005). "Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility". Carcinogenesis. 26 (12): 2046–9. doi:10.1093/carcin/bgi168. PMID15987717.
Tompkins V, Hagen J, Zediak VP, Quelle DE (Mar 2006). "Identification of novel ARF binding proteins by two-hybrid screening". Cell Cycle. 5 (6): 641–6. doi:10.4161/cc.5.6.2560. PMID16582619.
Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY (May 2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration". Cell. 125 (4): 801–14. doi:10.1016/j.cell.2006.03.032. PMID16713569.